Safety and effectiveness assessment of the surpass evolve (SEASE): a post-market international multicenter study

  • 0Department of Neurology, Neurosurgery & Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

|

|

Summary

This summary is machine-generated.

The Surpass Evolve (SE) flow diverter shows high effectiveness in treating intracranial aneurysms (iAs), with a 73% complete occlusion rate. This study confirms its favorable safety profile in real-world international use.

Area Of Science

  • Endovascular neurosurgery
  • Cerebrovascular disease management
  • Medical device technology

Background

  • Intracranial aneurysms (iAs) are a significant cause of morbidity and mortality.
  • Flow diverters represent a first-line treatment for specific iAs.
  • Limited data exists on the new-generation Surpass Evolve (SE) 64-wire flow diverter.

Purpose Of The Study

  • To evaluate the safety and effectiveness of the Surpass Evolve (SE) flow diverter.
  • To report the first international real-world experience with the SE device.
  • To assess complete occlusion rates and major adverse events following SE implantation for iAs.

Main Methods

  • A multicenter, retrospective, international, post-marketing cohort study (SEASE) was conducted.
  • Consecutive patients treated with SE for iAs between 2020-2022 were included.
  • Primary endpoints were complete aneurysm occlusion (Raymond-Roy Class 1) and major safety events (ischemia, hemorrhage, mortality).

Main Results

  • 305 patients with 332 iAs were treated with SE.
  • Median follow-up was 10.2 months, with 73.0% complete occlusion rate.
  • Major stroke occurred in 2% and procedure-related mortality in 0.7% of cases.

Conclusions

  • The Surpass Evolve (SE) flow diverter demonstrates high effectiveness in achieving complete occlusion of intracranial aneurysms.
  • SE exhibits a favorable safety profile, with low rates of major ischemic events and mortality.
  • This study supports the use of SE as a reliable treatment option for intracranial aneurysms in real-world clinical practice.